Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients?

被引:1
|
作者
Germani, Giacomo [1 ,2 ]
Tsochatzis, Emmanuel [1 ]
Burroughs, Andrew Kenneth [1 ]
机构
[1] Royal Free Sheila Sherlock Liver Ctr & Univ, Royal Free Hosp, Dept Surg, London, England
[2] Padua Univ Hosp, Dept Surg & Gastroenterol Sci, Padua, Italy
关键词
HEPATITIS-C; MYCOPHENOLATE-MOFETIL; AZATHIOPRINE; IMPACT;
D O I
10.1111/j.1432-2277.2011.01288.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:E77 / E78
页数:2
相关论文
共 50 条
  • [21] HCV INFECTION IN LIVER-TRANSPLANT RECIPIENTS
    BOURGEOIS, N
    SZNAJER, Y
    BOTEMBE, N
    LIESNARD, C
    MOONENS, F
    PENY, MO
    DEPREZ, C
    VANDESTADT, J
    GELIN, M
    ADLER, M
    GASTROENTEROLOGY, 1993, 104 (04) : A879 - A879
  • [22] Interferon-based treatment for recurrent HCV infection does not influence the progression of hepatic fibrosis in liver transplant recipients.
    Gan, D
    Fiel, MI
    Dubrovskaya, V
    Suriawinata, A
    Canchis, PW
    Hytiroglou, P
    Thung, SN
    Schiano, TD
    HEPATOLOGY, 2003, 38 (04) : 534A - 535A
  • [23] Diabetes in HCV positive liver transplant recipients
    Wang, BZ
    Fink, M
    Hughes, T
    Jones, R
    IMMUNOLOGY AND CELL BIOLOGY, 2005, 83 (04): : A19 - A20
  • [24] Impact of Everolimus Monotherapy on HCV Recurrence in Liver Transplant Recipients: Results of a Randomized Trial.
    Rompianesi, Gianluca
    Montalti, Roberto
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Ballarin, Roberto
    Tarantino, Giuseppe
    Iemmolo, Rosa Maria
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
  • [25] Graft Fibrosis in Stable Pediatric Liver Transplant Recipients: What Does It Mean?
    Magee, John C.
    HEPATOLOGY, 2009, 49 (03) : 726 - 728
  • [26] Contribution of donor liver steatosis to graft survival and viral recurrence in HCV-infected liver transplant recipients
    Briceno, J.
    Ciria, R.
    Pleguezuelo, M.
    Lopez-Cillero, P.
    Rufian, S.
    Lopez-Rubio, F.
    Mata, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S64 - S64
  • [27] Long-term maintenance of SVR in difficult-to-treat HCV genotypes in liver transplant recipients with HCV recurrence
    Ponziani, Francesca Romana
    Milani, Alessandro
    Gasbarrini, Antonio
    Zaccaria, Raffaella
    Vigano, Raffaella
    Iemmolo, Rosa Maria
    Donato, Maria F.
    Rendina, Maria
    Toniutto, Pierluigi
    Pasulo, Luisa
    Morelli, Maria Cristina
    Burra, Patrizia
    Miglioresi, Lucia
    Merli, Manuela
    Di Paolo, Daniele
    Fagiuoli, Stefano
    Pompili, Maurizio
    HEPATOLOGY, 2012, 56 : 1004A - 1004A
  • [28] Hepatitis C recurrence in liver transplant recipients
    Kizilisik, TA
    AlSebayel, M
    Hammad, A
    AlTraif, I
    Ramirez, CG
    Abdulla, A
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 2875 - 2877
  • [29] EARLY EVALUATION OF HISTOLOGICAL MARKERS OF FIBROSIS AND CELLULAR PROLIFERATION IN LIVER TRANSPLANT PATIENTS WITH HCV RECURRENCE
    Mensa, L.
    Marino, Z.
    Crespo, G.
    Lens, S.
    Miquel, R.
    Carrion, J.
    Perez-del-Pulgar, S.
    Forns, X.
    Navasa, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S75 - S75
  • [30] The Use of HCV Positive Donors in HCV Negative Liver Transplant Recipients
    Cholankeril, George
    Perumpail, Ryan B.
    Hu, Menghan
    Aggarwal, Avin
    Liu, Andy
    Kwong, Allison J.
    Dhanasekaran, Renumathy
    Bonham, Clark A.
    Gonzalez, Stevan A.
    Kim, W. Ray
    Esquivel, Carlos O.
    Ahmed, Aijaz
    HEPATOLOGY, 2016, 64 : 807A - 807A